Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.72 |
| ▸ | HSD17B1 | P14061 | 4/20 | 0.68 |
| ▸ | HSD17B2 | P37059 | 4/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.68 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.64 |
| ▸ | CA12 | O43570 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA6 | P23280 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.61 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.61 |
| ▸ | RXRA | P19793 | 4/20 | 0.59 |
| ▸ | RXRB | P28702 | 4/20 | 0.59 |
| ▸ | RXRG | P48443 | 1/20 | 0.59 |
| ▸ | BCL2 | P10415 | 1/20 | 0.59 |
| ▸ | KMO | O15229 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29876804 | 1.00 | EGFR (0.72) | EGFRHSD17B1HSD17B2CYP3A4CYP2C9 | |
| Benzoic Acid SCHEMBL23212129 | 0.90 | CA12 (0.69) | EGFRHSD17B1HSD17B2CYP3A4CYP2C9 | |
| SCHEMBL30066684 | 0.87 | KMO (0.72) | EGFRTRIM24TRIM33RXRARXRB | |
| SCHEMBL16166011 | 0.87 | KMO (0.72) | EGFRTRIM24TRIM33RXRARXRB | |
| SCHEMBL4677929 | 0.86 | HSD17B1 (0.71) | EGFRHSD17B1HSD17B2CYP3A4CYP2C9 | |
| SCHEMBL29876694 | 0.86 | CA12 (0.76) | EGFRHSD17B1HSD17B2CYP3A4CYP2C9 | |
| SCHEMBL4249787 | 0.86 | CA12 (0.76) | EGFRHSD17B1HSD17B2CYP3A4CYP2C9 | |
| SCHEMBL2346605 | 0.85 | KMO (0.76) | EGFRTRIM24TRIM33RXRARXRB | |
| SCHEMBL29906143 | 0.85 | KMO (0.76) | EGFRTRIM24TRIM33RXRARXRB | |
| Terephthalic Acid SCHEMBL4640732 | 0.85 | CA12 (0.74) | EGFRCYP3A4CHEK1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2167077-A2 | ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR | Bayer Schering Pharma Aktiengesellschaft (DE) | 2010-03-31 | — | — | EP | claimed |
| US-20090023741-A1 | ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR | BAYER SCHERING PHARMA AG (DE) | 2009-01-22 | — | — | US | claimed |
| WO-2008152099-A2 | ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-12-18 | — | — | WO | claimed |
| WO-1998014501-A1 | PROCESS FOR THE PREPARATION OF THERMOTROPIC AROMATIC POLYESTERS DIRECTLY FROM DIALKYL AROMATIC ESTERS | HOECHST CELANESE CORPORATION (US) | 1998-04-09 | — | — | WO | claimed |
| US-5731401-A | ONE STEP; HIGH MOLECULAR WEIGHT | HOECHST CELANESE CORP. (US) | 1998-03-24 | — | — | US | claimed |
| US-12448569-B2 | Liquid crystalline polymer composition and molded article produced therefrom | LOTTE CHEMICAL CORPORATION (KR) | 2025-10-21 | — | — | US | disclosed |
| US-20250122425-A1 | Liquid Crystalline Polymer Composition and Molded Article Produced Therefrom | LOTTE CHEMICAL CORPORATION (KR) | 2025-04-17 | — | — | US | disclosed |
| CN-117980412-A | Liquid crystal polymer composition and molded article prepared therefrom | 乐天化学株式会社 | 2024-05-03 | — | — | CN | disclosed |
| WO-2024043581-A1 | INSULATION FILM AND LAMINATE COMPRISING SAME | 코오롱인더스트리 주식회사 | 2024-02-29 | — | — | WO | disclosed |
| US-20240067600-A1 | SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP) | UNIVERSITY OF KANSAS (US) | 2024-02-29 | — | — | US | disclosed |
| WO-2023239103-A1 | LIQUID CRYSTAL POLYMER COMPOSITION AND MOLDED ARTICLE PRODUCED THEREFROM | 롯데케미칼 주식회사 | 2023-12-14 | — | — | WO | disclosed |
| CN-116178687-A | Wholly aromatic liquid crystal polyester and preparation method and application thereof | 金发科技股份有限公司 | 2023-05-30 | — | — | CN | disclosed |
| WO-1999010308-A1 | BIPHENYL DERIVATIVES SUBSTITUTED BY AN AROMATIC OR HETEROAROMATIC RADICAL AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME | GALDERMA RESEARCH & DEVELOPMENT (FR) | 1999-03-04 | — | — | WO | disclosed |
| US-5770683-A | Preparation process of polyhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-06-23 | — | — | US | disclosed |
| WO-1998014501-A1 | PROCESS FOR THE PREPARATION OF THERMOTROPIC AROMATIC POLYESTERS DIRECTLY FROM DIALKYL AROMATIC ESTERS | HOECHST CELANESE CORPORATION (US) | 1998-04-09 | — | — | WO | disclosed |
| US-5731401-A | ONE STEP; HIGH MOLECULAR WEIGHT | HOECHST CELANESE CORP. (US) | 1998-03-24 | — | — | US | disclosed |
| EP-0710684-A2 | Preparation process of polyhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-05-08 | — | — | EP | disclosed |
| EP-0044205-B1 | POLYESTER OF 6-HYDROXY-2-NAPHTHOIC ACID AND METAHYDROXY BENZOIC ACID CAPABLE OF READILY UNDERGOING MELT PROCESSING | CELANESE CORPORATION (US) | 1985-04-10 | — | — | EP | disclosed |
| US-4337190-A | Polyester of 6-hydroxy-2-naphthoic acid and meta-hydroxy benzoic acid capable of readily undergoing melt processing | CELANESE CORPORATION (US) | 1982-06-29 | — | — | US | disclosed |
| EP-0044205-A1 | Polyester of 6-hydroxy-2-naphthoic acid and metahydroxy benzoic acid capable of readily undergoing melt processing | CELANESE CORPORATION (US) | 1982-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240067600-A1 | SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP) | MTCH2, TIMM50, TIMM10 | EGFR 4412/4885HSD17B1 2304/4885HSD17B2 2360/4885 |
| US-20090023741-A1 | ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR | PTGER2, PTGER1, PTGDR2 | EGFR 888/4885HSD17B1 354/4885HSD17B2 232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.